BLUEBIRD STRATEGIES

Lobbying for ATA ACTION · Trade association focused on ensuring access to telehealth & remote delivery of healthcar

Amended

The filer submitted a later report covering this same period, so the amounts here have been replaced. Site totals count only the latest version. See the current filing, posted Jan 21, 2026.

Filing · LD-2 quarterly report Q4 termination

Reporting period

4th Quarter 2025

Oct 1 - Dec 31 · Posted Jan 14, 2026

Income

$10,000

What the client paid this registrant for the period.

Client based in

District of Columbia

Representation ended

Dec 31, 2025

The registrant reported terminating its work for this client.

Official filing document

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Health Issues

Access to Prescription Digital Therapeutics Act of 2025 (H.R.3288/S. 1702)

Bills named in this filing 2

H.R. 3288
Access to Prescription Digital Therapeutics Act of 2025
S. 1702
Access to Prescription Digital Therapeutics Act of 2025

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.